drugset / Trial / NCT06776029

Fecal Microbiota Transplantation for Radiation-Induced Proctopathy

NCT06776029 ↗

Phase 2 Recruiting 20 enrolled Sixth Affiliated Hospital, Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

The goal of this single-arm trial is to learn if Fecal Microbiota Transplantation (FMT) works to treat hemorrhagic radiation-induced proctopathy. The main questions it aims to answer are: * Dose FMT alleviate the symptom of severe rectal bleeding? * Dose FMT improve the endoscopic findings of proctopathy? Participants will: * Take fecal microbiota capsules by 8 sessions over a 12-week period. * Visit the clinic once every 4 weeks for checkups and tests. * Keep a diary of their symptoms and the number of times they use other supportive care.

Timeline

Start
2025-02-01
Primary completion
2026-03-31
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplantation Capsule Unknown 40 unknown Oral

Indications